Tia S Lewis

A biochemical rationale for the anticancer effects of Hsp90 inhibitors: Slow, tight binding inhibition by geldanamycin and its analogues

A. King, R. Copeland, P. Tummino, 2006, Proceedings of the National Academy of Sciences of the United States of America.

Modular Protein Ligation: A New Paradigm as a Reagent Platform for Pre-Clinical Drug Discovery

Beth L. Pietrak, Marc A. Holbert, Yong Jiang, 2019, Scientific Reports.

Characterization of Apo‐Form Selective Inhibition of Indoleamine 2,3‐Dioxygenase **

Douglas W. Thomson, Rodrigo F. Ortiz-Meoz, G. Bergamini, 2020, Chembiochem : a European journal of chemical biology.

Characterization of apo-form selective inhibition of indoleamine 2,3-dioxygenase

Douglas W. Thomson, Rodrigo F. Ortiz-Meoz, G. Bergamini, 2020, bioRxiv.

Characterization of novel inhibition of indoleamine 2,3-dioxygenase by targeting its apo form.

Douglas W. Thomson, Rodrigo F. Ortiz-Meoz, G. Bergamini, 2018 .

Optimized procedures for producing biologically active chemokines.

R. Ames, J. Foley, J. Fornwald, 2009, Protein expression and purification.

Development of a high-throughput screen to detect inhibitors of TRPS1 sumoylation.

Susheel Kumar, T. Meek, L. Szewczuk, 2013, Assay and drug development technologies.

Modular Protein Ligation: A New Paradigm as a Reagent Platform for Pre-Clinical Drug Discovery

Marc A. Holbert, Yong Jiang, L. Szewczuk, 2019, Scientific Reports.

Suppressing Posttranslational Gluconoylation of Heterologous Proteins by Metabolic Engineering of Escherichia coli

J. Aon, J. Kerrigan, Tia S Lewis, 2007, Applied and Environmental Microbiology.